Benefit of infliximab reintroduction after successive failure of infliximab and adalimumab in Crohn's disease.

C Gagniere , L Beaugerie (1, 2) , B Pariente , P Seksik (1) , Audrey Amiot (3) , V Abitbol (4) , M Allez , J Cosnes (1) , H Sokol (2, 1)

1 UPMC - Université Pierre et Marie Curie - Paris 6
2 CHU Saint-Antoine [AP-HP]
3 LETG-Angers - Littoral, Environnement, Télédétection, Géomatique
4 Laboratoire GlaxoSmithKline [ Marly-le-Roi]

Domaines: Chimie organique

C Gagniere, L Beaugerie, B Pariente, P Seksik, Audrey Amiot, et al.. Benefit of infliximab reintroduction after successive failure of infliximab and adalimumab in Crohn's disease.. Journal of Crohn's and Colitis, 2014, 9 (4), pp.349-355. ⟨10.1093/ecco-jcc/jju024⟩. ⟨hal-01103408⟩